
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17163171
[patent_doc_number] => 11149260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Simultaneous multiplex genome editing in yeast
[patent_app_type] => utility
[patent_app_number] => 17/319022
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 32387
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319022 | Simultaneous multiplex genome editing in yeast | May 11, 2021 | Issued |
Array
(
[id] => 17185562
[patent_doc_number] => 20210332447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => DNA IMPURITIES IN A COMPOSITION COMPRISING A PARVOVIRAL VIRION
[patent_app_type] => utility
[patent_app_number] => 17/313777
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313777 | DNA IMPURITIES IN A COMPOSITION COMPRISING A PARVOVIRAL VIRION | May 5, 2021 | Pending |
Array
(
[id] => 17214820
[patent_doc_number] => 20210348157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/246466
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 205269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246466
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246466 | NOVEL CRISPR ENZYMES AND SYSTEMS | Apr 29, 2021 | Pending |
Array
(
[id] => 17037122
[patent_doc_number] => 20210254080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => MANIPULATION OF GENES INVOLVED IN SIGNAL TRANSDUCTION TO CONTROL FUNGAL MORPHOLOGY DURING FERMENTATION AND PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/245928
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245928 | Manipulation of genes involved in signal transduction to control fungal morphology during fermentation and production | Apr 29, 2021 | Issued |
Array
(
[id] => 17214819
[patent_doc_number] => 20210348156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/246460
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 205063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246460 | NOVEL CRISPR ENZYMES AND SYSTEMS | Apr 29, 2021 | Pending |
Array
(
[id] => 17482674
[patent_doc_number] => 20220090178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => DEVICES FOR CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 17/241382
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241382 | DEVICES FOR CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS | Apr 26, 2021 | Pending |
Array
(
[id] => 17135026
[patent_doc_number] => 11136572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Simultaneous multiplex genome editing in yeast
[patent_app_type] => utility
[patent_app_number] => 17/230241
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 41
[patent_no_of_words] => 35194
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230241 | Simultaneous multiplex genome editing in yeast | Apr 13, 2021 | Issued |
Array
(
[id] => 18337944
[patent_doc_number] => 20230129893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => GENE THERAPY FOR TREATING PROPIONIC ACIDEMIA
[patent_app_type] => utility
[patent_app_number] => 17/906902
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906902 | GENE THERAPY FOR TREATING PROPIONIC ACIDEMIA | Mar 29, 2021 | Pending |
Array
(
[id] => 19923234
[patent_doc_number] => 12297505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Algorithms for disease diagnostics
[patent_app_type] => utility
[patent_app_number] => 17/218127
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28552
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 314
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218127 | Algorithms for disease diagnostics | Mar 29, 2021 | Issued |
Array
(
[id] => 17097202
[patent_doc_number] => 20210284993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/207376
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207376 | HTP genomic engineering platform for improving fungal strains | Mar 18, 2021 | Issued |
Array
(
[id] => 17214906
[patent_doc_number] => 20210348243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => RAPID FIELD-DEPLOYABLE DETECTION OF SARS-CoV-2 VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/206020
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206020 | RAPID FIELD-DEPLOYABLE DETECTION OF SARS-CoV-2 VIRUS | Mar 17, 2021 | Pending |
Array
(
[id] => 17428807
[patent_doc_number] => 20220056515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHODS OF IDENTIFYING MULTIPLE EPITOPES IN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/204325
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204325 | METHODS OF IDENTIFYING MULTIPLE EPITOPES IN CELLS | Mar 16, 2021 | Abandoned |
Array
(
[id] => 17242036
[patent_doc_number] => 20210361779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING VIRAL COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 17/201347
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201347 | DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING VIRAL COMPONENTS | Mar 14, 2021 | Pending |
Array
(
[id] => 17015403
[patent_doc_number] => 11085030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => MAD nucleases
[patent_app_type] => utility
[patent_app_number] => 17/200074
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 10623
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200074 | MAD nucleases | Mar 11, 2021 | Issued |
Array
(
[id] => 17267700
[patent_doc_number] => 11193115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Mad nucleases
[patent_app_type] => utility
[patent_app_number] => 17/200110
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11062
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200110 | Mad nucleases | Mar 11, 2021 | Issued |
Array
(
[id] => 17221980
[patent_doc_number] => 11174471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Mad nucleases
[patent_app_type] => utility
[patent_app_number] => 17/200089
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11073
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200089 | Mad nucleases | Mar 11, 2021 | Issued |
Array
(
[id] => 16916411
[patent_doc_number] => 20210189503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => BIOMARKERS FOR DETERMINING RESPONSIVENESS OF A CANCER TO PI3K INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/182700
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182700 | BIOMARKERS FOR DETERMINING RESPONSIVENESS OF A CANCER TO PI3K INHIBITORS | Feb 22, 2021 | Abandoned |
Array
(
[id] => 16868555
[patent_doc_number] => 20210162022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 17/168971
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168971 | Sequence specific antimicrobials | Feb 4, 2021 | Issued |
Array
(
[id] => 16992210
[patent_doc_number] => 20210230630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => INDUCIBLE MODIFICATION OF A CELL GENOME
[patent_app_type] => utility
[patent_app_number] => 17/166823
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166823 | Inducible modification of a cell genome | Feb 2, 2021 | Issued |
Array
(
[id] => 16999662
[patent_doc_number] => 11078458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Genome-wide rationally-designed mutations leading to enhanced lysine production in
[patent_app_type] => utility
[patent_app_number] => 17/159137
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7431
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159137 | Genome-wide rationally-designed mutations leading to enhanced lysine production in | Jan 25, 2021 | Issued |